Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus

Standard

Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus. / Moser, Julia M; Willems, Stephan; Andresen, Dietrich; Brachmann, Johannes; Eckardt, Lars; Hoffmann, Ellen; Kuck, Karl-Heinz; Lewalter, Thorsten; Schumacher, Burghard; Spitzer, Stefan G; Hochadel, Matthias; Senges, Jochen; Hoffmann, Boris A.

In: J CARDIOVASC ELECTR, Vol. 28, No. 3, 03.2017, p. 258-265.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Moser, JM, Willems, S, Andresen, D, Brachmann, J, Eckardt, L, Hoffmann, E, Kuck, K-H, Lewalter, T, Schumacher, B, Spitzer, SG, Hochadel, M, Senges, J & Hoffmann, BA 2017, 'Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus', J CARDIOVASC ELECTR, vol. 28, no. 3, pp. 258-265. https://doi.org/10.1111/jce.13142

APA

Moser, J. M., Willems, S., Andresen, D., Brachmann, J., Eckardt, L., Hoffmann, E., Kuck, K-H., Lewalter, T., Schumacher, B., Spitzer, S. G., Hochadel, M., Senges, J., & Hoffmann, B. A. (2017). Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus. J CARDIOVASC ELECTR, 28(3), 258-265. https://doi.org/10.1111/jce.13142

Vancouver

Moser JM, Willems S, Andresen D, Brachmann J, Eckardt L, Hoffmann E et al. Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus. J CARDIOVASC ELECTR. 2017 Mar;28(3):258-265. https://doi.org/10.1111/jce.13142

Bibtex

@article{7004f348cd7c4161bc042a5c30841876,
title = "Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus",
abstract = "INTRODUCTION: Despite a rising demand for catheter ablation (CA) of atrial fibrillation (AF) in an elderly population, complication and success rates are not fully elucidated. We sought to compare complication rates of CA of AF in patients ≥75 versus <75 years of age.METHODS AND RESULTS: Patients with symptomatic, drug-refractory AF were prospectively enrolled from January 2007 to 2010 in this multicenter study. A total of 4,449 patients, group 1 ≥75 years and group 2 <75 years (n = 227, age 77.3 ± 2.2 vs. 59.7 ± 9.8 years, 52.0% vs. n = 4,222, 68.9% male, CHA2 DS2 -VASc-Score 3.7 ± 1.0 vs. 1.7 ± 1.2; P < 0.001, respectively), with paroxysmal AF (59.9% in group 1 vs. 63.3% in group 2, P = 0.30), and persistent AF (34.8% in group 1 vs. 29.4% in group 2, P = 0.082) underwent CA of AF. A centralized follow-up was obtained in 4,347 patients by the Institute for Myocardial Infarction Research (IHF, Ludwigshafen). There was a significant difference between periprocedural stroke rates in the elderly versus the younger cohort (1.3% vs. 0.1%, P < 0.01). In-hospital severe nonfatal complications did not differ significantly between the groups (4.4% vs. 2.7%, P = 0.14). Other procedure-related, in-hospital complications were not significantly different. After a mean follow-up of 472 ± 99 days (group 1) and 477 ± 94 days (group 2), no differences were found in complication rates.CONCLUSION: CA of AF in patients ≥75 years is associated with higher in-hospital stroke rates. In a 1-year follow-up, complication rates do not differ between the groups.",
keywords = "Action Potentials, Age Factors, Aged, Atrial Fibrillation/diagnosis, Catheter Ablation/adverse effects, Disease-Free Survival, Female, Germany, Heart Rate, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prospective Studies, Pulmonary Veins/physiopathology, Registries, Risk Factors, Stroke/etiology, Time Factors, Treatment Outcome",
author = "Moser, {Julia M} and Stephan Willems and Dietrich Andresen and Johannes Brachmann and Lars Eckardt and Ellen Hoffmann and Karl-Heinz Kuck and Thorsten Lewalter and Burghard Schumacher and Spitzer, {Stefan G} and Matthias Hochadel and Jochen Senges and Hoffmann, {Boris A}",
note = "{\textcopyright} 2016 Wiley Periodicals, Inc.",
year = "2017",
month = mar,
doi = "10.1111/jce.13142",
language = "English",
volume = "28",
pages = "258--265",
journal = "J CARDIOVASC ELECTR",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus

AU - Moser, Julia M

AU - Willems, Stephan

AU - Andresen, Dietrich

AU - Brachmann, Johannes

AU - Eckardt, Lars

AU - Hoffmann, Ellen

AU - Kuck, Karl-Heinz

AU - Lewalter, Thorsten

AU - Schumacher, Burghard

AU - Spitzer, Stefan G

AU - Hochadel, Matthias

AU - Senges, Jochen

AU - Hoffmann, Boris A

N1 - © 2016 Wiley Periodicals, Inc.

PY - 2017/3

Y1 - 2017/3

N2 - INTRODUCTION: Despite a rising demand for catheter ablation (CA) of atrial fibrillation (AF) in an elderly population, complication and success rates are not fully elucidated. We sought to compare complication rates of CA of AF in patients ≥75 versus <75 years of age.METHODS AND RESULTS: Patients with symptomatic, drug-refractory AF were prospectively enrolled from January 2007 to 2010 in this multicenter study. A total of 4,449 patients, group 1 ≥75 years and group 2 <75 years (n = 227, age 77.3 ± 2.2 vs. 59.7 ± 9.8 years, 52.0% vs. n = 4,222, 68.9% male, CHA2 DS2 -VASc-Score 3.7 ± 1.0 vs. 1.7 ± 1.2; P < 0.001, respectively), with paroxysmal AF (59.9% in group 1 vs. 63.3% in group 2, P = 0.30), and persistent AF (34.8% in group 1 vs. 29.4% in group 2, P = 0.082) underwent CA of AF. A centralized follow-up was obtained in 4,347 patients by the Institute for Myocardial Infarction Research (IHF, Ludwigshafen). There was a significant difference between periprocedural stroke rates in the elderly versus the younger cohort (1.3% vs. 0.1%, P < 0.01). In-hospital severe nonfatal complications did not differ significantly between the groups (4.4% vs. 2.7%, P = 0.14). Other procedure-related, in-hospital complications were not significantly different. After a mean follow-up of 472 ± 99 days (group 1) and 477 ± 94 days (group 2), no differences were found in complication rates.CONCLUSION: CA of AF in patients ≥75 years is associated with higher in-hospital stroke rates. In a 1-year follow-up, complication rates do not differ between the groups.

AB - INTRODUCTION: Despite a rising demand for catheter ablation (CA) of atrial fibrillation (AF) in an elderly population, complication and success rates are not fully elucidated. We sought to compare complication rates of CA of AF in patients ≥75 versus <75 years of age.METHODS AND RESULTS: Patients with symptomatic, drug-refractory AF were prospectively enrolled from January 2007 to 2010 in this multicenter study. A total of 4,449 patients, group 1 ≥75 years and group 2 <75 years (n = 227, age 77.3 ± 2.2 vs. 59.7 ± 9.8 years, 52.0% vs. n = 4,222, 68.9% male, CHA2 DS2 -VASc-Score 3.7 ± 1.0 vs. 1.7 ± 1.2; P < 0.001, respectively), with paroxysmal AF (59.9% in group 1 vs. 63.3% in group 2, P = 0.30), and persistent AF (34.8% in group 1 vs. 29.4% in group 2, P = 0.082) underwent CA of AF. A centralized follow-up was obtained in 4,347 patients by the Institute for Myocardial Infarction Research (IHF, Ludwigshafen). There was a significant difference between periprocedural stroke rates in the elderly versus the younger cohort (1.3% vs. 0.1%, P < 0.01). In-hospital severe nonfatal complications did not differ significantly between the groups (4.4% vs. 2.7%, P = 0.14). Other procedure-related, in-hospital complications were not significantly different. After a mean follow-up of 472 ± 99 days (group 1) and 477 ± 94 days (group 2), no differences were found in complication rates.CONCLUSION: CA of AF in patients ≥75 years is associated with higher in-hospital stroke rates. In a 1-year follow-up, complication rates do not differ between the groups.

KW - Action Potentials

KW - Age Factors

KW - Aged

KW - Atrial Fibrillation/diagnosis

KW - Catheter Ablation/adverse effects

KW - Disease-Free Survival

KW - Female

KW - Germany

KW - Heart Rate

KW - Humans

KW - Kaplan-Meier Estimate

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - Pulmonary Veins/physiopathology

KW - Registries

KW - Risk Factors

KW - Stroke/etiology

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1111/jce.13142

DO - 10.1111/jce.13142

M3 - SCORING: Journal article

C2 - 27925337

VL - 28

SP - 258

EP - 265

JO - J CARDIOVASC ELECTR

JF - J CARDIOVASC ELECTR

SN - 1045-3873

IS - 3

ER -